← All trials
NCT06326996
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 10, 2024
- Primary completion
- Jun 29, 2025
- Completion date
- Sep 29, 2025
- First posted
- Mar 25, 2024
- Last posted
- Oct 30, 2024
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of California, Los AngelesLead sponsor
- University of California, Los AngelesSponsor investigator
- University of California, Los AngelesOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.